Skip to main content
Medical information Clinical review pending

Genetic Testing

GP1BA Gene Von Willebrand Disease Platelet Type Genetic Test

Genetic test for von Willebrand disease, a bleeding disorder related to platelet function. Uses Next Generation Sequencing (NGS) to analyze the GP1BA gene. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Confirm turnaround time with the laboratory before booking.
Preparation
No special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the GP1BA Gene Von Willebrand Disease Platelet Type Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained bleeding or bruising
  • ✓Family history of von Willebrand disease
  • ✓Excessive bleeding during surgery or dental procedures
  • ✓Suspected platelet function disorder
  • ✓Genetic counseling for family planning
02

In plain language

What this test helps you understand

This test helps diagnose von Willebrand disease, a bleeding disorder, by identifying mutations in the GP1BA gene. It aids in understanding the genetic basis of the condition and can inform management strategies.
The GP1BA Gene Von Willebrand Disease Platelet Type NGS Genetic DNA Test is a diagnostic tool using Next Generation Sequencing (NGS) technology. It identifies genetic mutations linked to von Willebrand disease, a common bleeding disorder. This test is important for individuals potentially at risk, enabling early diagnosis and management.

This genetic test examines the GP1BA gene, which plays a key role in normal platelet function. Detecting mutations in this gene helps healthcare providers confirm a diagnosis of von Willebrand disease and understand its severity.

Individuals experiencing unexplained bleeding or bruising, those with a family history of von Willebrand disease, or those with excessive bleeding during medical procedures may benefit from this test. People with a known family history of GP1BA mutations might also consider testing for proactive health management.

Taking this test can provide an accurate diagnosis, inform treatment decisions, aid in genetic counseling for family planning, and offer peace of mind.

Results will show if mutations are present in the GP1BA gene. A healthcare provider will help interpret the results and discuss next steps, such as treatment or lifestyle changes.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) is used to analyze the GP1BA gene for mutations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the GP1BA gene. Von Willebrand disease can sometimes be caused by mutations in other genes or factors not detected by this test. A negative result does not completely rule out von Willebrand disease. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Von Willebrand disease is a common inherited bleeding disorder where the blood doesn't clot properly due to a deficiency or dysfunction of von Willebrand factor, a protein crucial for platelet adhesion.
The GP1BA gene provides instructions for making a protein called glycoprotein Ib-alpha. This protein is found on the surface of platelets and is essential for platelets to stick to damaged blood vessel walls, a key step in clot formation.
Individuals with symptoms like easy bruising, frequent nosebleeds, heavy menstrual periods, or prolonged bleeding after injury or surgery, especially if there's a family history of bleeding disorders, should discuss testing with their doctor.
A blood sample is typically collected for this test. The laboratory can provide details on the collection process, including options for home sample collection.
Results will indicate whether specific mutations associated with von Willebrand disease were found in the GP1BA gene. Your doctor will interpret these results in the context of your medical history and symptoms.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp